ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014

Wendy Will Case Found Invites Applications For Small Grants

April 5, 1991

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

Clinical Oncology Program Has Top Priority Fink Says

February 9, 1979

President’s Cancer Panel annual report finds barriers in translational research stall progress.

July 8, 2005